CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study

2015

Lancet Oncology, The - In Press.Proof corrected by the author Available online since mercredi 15 juillet 2015

Keywords:

References

Citations